Hypnosis for management of breathlessness and anxiety in severe and palliative-care COPD patients: a sham-controlled crossover trial

Bligny Hospital Center0 个研究点目标入组 21 人开始时间: 2020年1月7日最近更新: 2023年3月13日

适应症

试验速览

2020 Results article in https://doi.org/10.2147/COPD.S267019 results (added 23/10/2020) 2022 Protocol article in https://doi.org/10.1183/23120541.00565-2021 (added 28/02/2023)

•1. Aged 35-80 years
•2. Affiliated to a Social Security scheme or beneficiary of such a scheme
•3. Absence of neurological disease interfering with the passing of tests
•4. Capable of giving free, informed consent.
•5. Severe COPD with dyspnea and distension
•6. Hospitalized, with or without a tracheotomy
•7. Non-obese
•8. Predicted FEV1 <60% and FEV/FVC <70%, with distension evidenced by chest x-ray or predicted TLC >120% in pulmonary function tests
•9. Severity marked by ongoing hospitalization, with at least one prior instance of decompensation
•10. Dyspneic, with resting Borg Scale score =3
•11. Not having yet participated in the complementary care protocol offered by the hospital, a pulmonary rehabilitation program (PRP) protocol, or any hypnosis protocol

•1. Pregnancy
•2. Mechanical ventilation during the session
•3. Known severe cardiac insufficiency
•4. Known severe pulmonary arterial hypertension
•5. Cancer diagnosis
•6. Significant cognitive impairment, hypercapnic encephalopathy or confusional syndrome
•7. Deafness
•8. Anemia (hemoglobin =8 g/dl)
•9. Psychotic pathology
•10. Anti-epileptic treatment

发起方

Bligny Hospital Center